ArticleScience signaling2013

The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells.

Aaron S Meyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.